An additional 3 breast and ovarian cancer cases were not analyzed in this cohort because in additional to RAD51B germline mutations, they carried another high or moderate penetrance mutation in a cancer susceptibility gene (1 each BRCA2, RAD51D, ATM). This evidence concerns the gene RAD51D and cancer.